Published April 29, 2010 | Version v1
Journal article

Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade

  • 1. Department of Gynecology and obstetrics, the first affiliated hospital of Sun Yat-sen University, Guangdong, Guangzhou, 510089 (China)
  • 2. Department of Gynecology and obstetrics, Guangzhou first municipal people's hospital, Guangdong, Guangzhou, 510180 (China)
  • 3. Laboratory of General Surgery, the first affiliated hospital of Sun Yat-sen University, Guangdong, Guangzhou, 510089 (China)
  • 4. Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangdong, Guangzhou, 510089 (China)

Description

The elevated expression of vascular endothelial growth factor C (VEGF-C) is correlated with clinical cervical cancer metastasis and patient survival, which is interpreted by VEGF-C functions to stimulate angiogenesis and lymphatic genesis. However, the direct impact of VEGF-C on cervical cancer cell motility remains largely unknown. In this study, we investigated the effects of VEGF-C on actin cytoskeleton remodeling and on cervical cancer cell migration and invasion and how the actin-regulatory protein, moesin regulated these effects through RhoA/ROCK-2 signaling pathway. On cervical carcinoma cell line SiHa cells, exposure of VEGF-C triggered remodeling of the actin cytoskeleton and the formation of membrane ruffles, which was required for cell movement. VEGF-C significantly enhanced SiHa cells horizontal migration and three-dimensional invasion into matrices. These actions were dependent on increased expression and phosphorylation of the actin-regulatory protein moesin and specific moesin siRNA severely impaired VEGF-C stimulated-cell migration. The extracellular small GTPase RhoA/ROCK-2 cascade mediated the increased moesin expression and phosphorylation, which was discovered by the use of Y-27632, a specific inhibitor of Rho kinase and by transfected constitutively active, dominant-negative RhoA as well as ROCK-2 SiRNA. Furthermore, in the surgical cervical specimen from the patients with FIGO stage at cervical intra-epithelial neoplasia and I-II cervical squamous cell carcinoma, the expression levels of moesin were found to be significantly correlated with tumor malignancy and metastasis. These results implied that VEGF-C promoted cervical cancer metastasis by upregulation and activation of moesin protein through RhoA/ROCK-2 pathway. Our findings offer new insight into the role of VEGF-C on cervical cancer progression and may provide potential targets for cervical cancer therapy

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-10-170; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873393

Additional details

Publishing Information

Journal Title
BMC Cancer (Online)
Journal Volume
10
Journal Page Range
p. 170
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46093245
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ACTIN; ANGIOGENESIS; CARCINOMAS; GROWTH FACTORS; MEMBRANES; MIGRATION; ORIGIN; PATIENTS; PHOSPHORYLATION; THERAPY
Descriptors DEC
CHEMICAL REACTIONS; DISEASES; MEDICINE; MITOGENS; NEOPLASMS; ORGANIC COMPOUNDS; PROTEINS

Optional Information

Copyright
Copyright (c)2010 He et al
Notes
PMCID: PMC2873393; PUBLISHER-ID: 1471-2407-10-170; PMID: 20429915; OAI: oai:pubmedcentral.nih.gov:2873393; licensee BioMed Central Ltd.